来自MSN

Exact Sciences’ MCED Test Study: A Potential Game-Changer in Early Cancer Detection

Exact Sciences Corp ((EXAS)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
The Globe and Mail

Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data being presented at the American College of Gastroenterology (ACG) Annual ...